Does RIVAROXABAN Cause Bladder cancer recurrent? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Bladder cancer recurrent have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.0% of all adverse event reports for RIVAROXABAN.
5
Reports of Bladder cancer recurrent with RIVAROXABAN
0.0%
of all RIVAROXABAN reports
0
Deaths
3
Hospitalizations
How Dangerous Is Bladder cancer recurrent From RIVAROXABAN?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Bladder cancer recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RIVAROXABAN Cause?
Gastrointestinal haemorrhage (20,041)
Haemorrhage (6,571)
Epistaxis (5,629)
Rectal haemorrhage (4,501)
Off label use (4,463)
Haematuria (4,387)
Upper gastrointestinal haemorrhage (4,247)
Cerebrovascular accident (4,111)
Anaemia (3,907)
Acute kidney injury (3,735)
What Other Drugs Cause Bladder cancer recurrent?
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (231)
PIOGLITAZONE (130)
RANITIDINE (66)
BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN (28)
MITOMYCIN (20)
PEMBROLIZUMAB (20)
ADALIMUMAB (19)
GEMCITABINE\GEMCITABINE (19)
METHOTREXATE (16)
GEMCITABINE (15)
Which RIVAROXABAN Alternatives Have Lower Bladder cancer recurrent Risk?
RIVAROXABAN vs RIVASTIGMINE
RIVAROXABAN vs RIVOTRIL
RIVAROXABAN vs RIZATRIPTAN
RIVAROXABAN vs ROACTEMRA
RIVAROXABAN vs ROCURONIUM